Generic placeholder image

Coronaviruses

Editor-in-Chief

ISSN (Print): 2666-7967
ISSN (Online): 2666-7975

Review Article

A New Threat to Mankind: COVID 19 - All You Need to Know

Author(s): Mrunali Patil* and Tosh Patil

Volume 2, Issue 3, 2021

Published on: 15 September, 2020

Page: [346 - 352] Pages: 7

DOI: 10.2174/2666796701999200915145630

Abstract

The devastating COVID 19 Pandemic, which set an outbreak by the end of 2019, has led the whole world into an alarming situation. So, considering the need of the time, we decided to put some light on the important aspects of the pandemic. Here we have discussed the different coronaviruses which can affect humans and also how this new coronavirus is different than the previously identified coronaviruses. In general, SARS CoV-2 is elaborated along with origin, virology, and transmission. The disease (COVID 19) is studied and briefed for its prognosis and symptoms and as to how the detection of the infection is done. As we know that we have not found any full proof solution for this outbreak but can fight it to save mankind, the need for new drug development and the current scenario on available options is discussed along with how the world is combatting the situation to stop its spread. Also, the common myths among the public about the disease are busted here. The paper is concluded with the current statistics of the outbreak. The purpose of this paper is to provide the general public with some know-how of the pandemic.

Keywords: SARS CoV-2, COVID 19, Coronaviruses (CoVs), pandemic, 2019nCoV, pneumonia, RT-PCR.

Graphical Abstract
[1]
Algahtani H, Subahi A, Shirah B. Neurological complications of Middle East respiratory syndrome coronavirus: a report of two cases and review of the literature. Case Rep Neurol Med 2016; 20163502683
[http://dx.doi.org/10.1155/2016/3502683] [PMID: 27239356]
[2]
Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Mil Med Res 2020; 7(1): 1-10.
[http://dx.doi.org/10.1186/s40779-020-00240-0] [PMID: 31928528]
[3]
Gaunt ER, Hardie A, Claas EC, Simmonds P, Templeton KE. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol 2010; 48(8): 2940-7.
[http://dx.doi.org/10.1128/JCM.00636-10] [PMID: 20554810]
[4]
Centers for Disease Control and Prevention. Human Coronavirus Types Available from: https://www.cdc.gov/coronavirus/types.html
[5]
Peeri NC, Shrestha N, Rahman MS, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol 2020; 49(3): 717-26.
[http://dx.doi.org/10.1093/ije/dyaa033.]
[6]
Bradburne AF, Bynoe ML, Tyrrell DA. Effects of a “new” human respiratory virus in volunteers. BMJ 1967; 3(5568): 767-9.
[http://dx.doi.org/10.1136/bmj.3.5568.767] [PMID: 6043624]
[7]
van der Hoek L, Sure K, Ihorst G, et al. Croup is associated with the novel coronavirus NL63. PLoS Med 2005; 2(8)e240
[http://dx.doi.org/10.1371/journal.pmed.0020240] [PMID: 16104827]
[8]
Beidas M, Chehadeh W. Effect of human coronavirus OC43 structural and accessory proteins on the transcriptional activation of antiviral response elements. Intervirology 2018; 61(1): 30-5.
[http://dx.doi.org/10.1159/000490566] [PMID: 30041172]
[9]
Dominguez SR, Travanty EA, Qian Z, Mason RJ. Human coronavirus HKU1 infection of primary human type II alveolar epithelial cells: cytopathic effects and innate immune response. PLoS One 2013; 8(7)e70129
[http://dx.doi.org/10.1371/journal.pone.0070129] [PMID: 23894604]
[10]
Killerby ME, Biggs HM, Midgley CM, Gerber SI, Watson JT. Middle East respiratory syndrome coronavirus transmission. Emerg Infect Dis 2020; 26(2): 191-8.
[http://dx.doi.org/10.3201/eid2602.190697] [PMID: 31961300]
[11]
World Health Organization.Coronavirus. Available from:. https://www.who.int/health-topics/coronavirus
[12]
WHO World Health Organization Available from: https://www.who.int
[13]
World Health Organization. Director-General’s opening remarks at the media briefing on COVID-19 – 11 March 2020 Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march
[14]
Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8(4): 420-2.
[http://dx.doi.org/10.1016/S2213-2600(20)30076-X] [PMID: 32085846]
[15]
Guan WJ, Ni ZY, Hu Y, et al. China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382(18): 1708-20.
[http://dx.doi.org/10.1056/NEJMoa2002032] [PMID: 32109013]
[16]
Poon LL, Chan KH, Wong OK, et al. Early diagnosis of SARS coronavirus infection by real time RT-PCR. J Clin Virol 2003; 28(3): 233-8.
[http://dx.doi.org/10.1016/j.jcv.2003.08.004] [PMID: 14522060]
[17]
Cascella M, Rajnik M, Cuomo A, et al. Features, evaluation and treatment Coronavirus (COVID-19) StatPearls. Treasure Island, FL: StatPearls Publishing 2020.
[18]
McIntosh K, Hirsch MS, Bloom A. Coronavirus disease 2019 (COVID-19): Epidemiology, virology, and prevention Available from: https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-epidemiology-virology-and-prevention
[19]
Hoffmann M, Kleine-Weber H, Krueger N, Mueller MA, Drosten C, Pöhlmann S. The novel Coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv 2020; 2020: 1.
[http://dx.doi.org/10.1101/2020.01.31.929042]
[20]
Chan JFW, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to- person transmission: a study of a family cluster. Lancet 2020; 395(10223): 514-23.
[http://dx.doi.org/10.1016/S0140-6736(20)30154-9] [PMID: 31986261]
[21]
Van Doremalen N, Bushmaker T, Morris D, et al. Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS- CoV-1. MedRxiv 2020; 382: 1564-7.
[http://dx.doi.org/10.1056/NEJMc2004973]
[22]
Xu YH, Dong JH, An WM, et al. Clinical and computed tomographic imaging features of Novel Coronavirus pneumonia caused by SARS-CoV-2. J Infect 2020; 80(4): 394-400.
[http://dx.doi.org/doi.org/10.1016/j.jinf.2020.02.017]
[23]
U.S.A. Today . What does the coronavirus do to your body? Everything to know about the infection process Available from: https://www.usatoday.com/in-depth/news/2020/03/13/what-coronavirus-does-body-covid-19-infection-process-symptoms/5009057002/
[24]
Corman V, Bleicker T, Brünink S, Zambon M. Diagnostic detection of Wuhan coronavirus 2019 by real-time RT-PCR. Euro Surveill 2020; 25(3)2000045
[http://dx.doi.org/10.2807/1560-7917.ES.2020.25.3.2000045]
[25]
Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 2020; 25(3)2000045
[http://dx.doi.org/10.2807/1560-7917.ES.2020.25.3.2000045] [PMID: 31992387]
[26]
Chu DK, Pan Y, Cheng S, et al. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem 2020; 66(4): 549-55.
[http://dx.doi.org/10.1093/clinchem/hvaa029]
[27]
Yang M, Hon KL, Li K, Fok TF, Li CK. The effect of SARS coronavirus on blood system: its clinical findings and the pathophysiologic hypothesis. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2003; 11(3): 217-21.
[PMID: 12844398]
[28]
Pfaffl MW. Quantification strategies in real-time PCR AZ of quantitative. PCR 2004; 1: 89-113.
[29]
Pfaffl MW. Quantification strategies in real-time polymerase chain reaction. Quantitative real-time PCR. Appl Microbiol 2012; 2012: 53-62.
[30]
Wang S, Kang B, Ma J, et al. A deep learning algorithm using CT images to screen for Corona Virus Disease (COVID-19). MedRxiv 2020; 2020: 1.
[http://dx.doi.org/doi.org/10.1101/2020.02.14.20023028]
[31]
Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends 2020; 14(1): 69-71.
[http://dx.doi.org/10.5582/bst.2020.01020]
[32]
Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents 2020; 55(3)105924
[http://dx.doi.org/10.1016/j.ijantimicag.2020.105924] [PMID: 32081636]
[33]
Clinicaltrials.gov. Clinicaltrials database. Available from:. https://clinicaltrials.gov/ct2/home
[34]
Roberts M. Coronavirus US volunteers test first vaccine Available from: https://www.bbc.com/news/health-51906604
[35]
Lloyd-Smith JO, Galvani AP, Getz WM. Curtailing transmission of severe acute respiratory syndrome within a community and its hospital. Proc Biol Sci 2003; 270(1528): 1979-89.
[http://dx.doi.org/10.1098/rspb.2003.2481] [PMID: 14561285]
[36]
] World Health Organization. Coronavirus disease (COVID-19) advice for the public. Available from:. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public
[37]
World Health Organization. Coronavirus disease (COVID-19) advice for the public: Mythbusters. Available from: . https://www. who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-busters
[38]
World Health Organization. Coronavirus disease (COVID-19). Available from:. https://www.who.int/news-room/q-a-detail/q-a-coronaviruses
[39]
World Health Organization. Coronavirus disease 2019 (COVID- 19) Situation Report – 32. Available from:. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200221-sitrep-32-covid-19.pdf?sfvrsn=4802d089_2
[40]
Worldometer. Coronavirus. Available from:. https://www.worldometers.info/coronavirus/

© 2022 Bentham Science Publishers | Privacy Policy